SCHEMBL6872504

SCHEMBL6872504

CCCCCCCCCCCC(CC)(CC(=O)O)C(=O)OCC(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.42
CYP4A11 Q02928 1/20 0.42
MAPT P10636 2/20 0.36
EPHX1 P07099 1/20 0.36
HSPD1 P10809 1/20 0.35
BLM P54132 1/20 0.35
HSPE1 P61604 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TDP1 Q9NUW8 2/20 0.35
FFAR1 O14842 1/20 0.35
CPT2 P23786 1/20 0.35
PAM P19021 2/20 0.34
ASAH1 Q13510 3/20 0.34
GPR84 Q9NQS5 2/20 0.33
PPARG P37231 2/20 0.33
PPARD Q03181 2/20 0.33
PPARA Q07869 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6870881 1.00 CYP4F2 (0.42) CYP4F2CYP4A11MAPTEPHX1HSPD1
SCHEMBL6871551 1.00 CYP4F2 (0.42) CYP4F2CYP4A11MAPTEPHX1HSPD1
SCHEMBL6872030 1.00 CYP4F2 (0.42) CYP4F2CYP4A11MAPTEPHX1HSPD1
SCHEMBL6863410 1.00 CYP4F2 (0.42) CYP4F2CYP4A11MAPTEPHX1HSPD1
SCHEMBL6874398 1.00 CYP4F2 (0.42) CYP4F2CYP4A11MAPTEPHX1HSPD1
SCHEMBL6873143 1.00 CYP4F2 (0.42) CYP4F2CYP4A11MAPTEPHX1HSPD1
SCHEMBL6870852 1.00 CYP4F2 (0.42) CYP4F2CYP4A11MAPTEPHX1HSPD1
SCHEMBL6870440 0.99 CYP4F2 (0.43) CYP4F2CYP4A11MAPTEPHX1HSPD1
SCHEMBL6863449 0.94 CYP4F2 (0.41) CYP4F2CYP4A11MAPTEPHX1HSPD1
SCHEMBL2455719 0.89 MAPT (0.42) CYP4F2CYP4A11MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165633-B1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE SPA (IT) 2004-07-14 EP disclosed
US-6716939-B2 COMPRISING TITANIUM, MAGNESIUM, HALOGEN AND AN ELECTRON DONOR COMPOUND SELECTED FROM ESTERS OF SUBSTITUTED SUCCINIC ACIDS BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2004-04-06 US disclosed
US-20020183575-A1 Components and catalysts for the polymerization of olefins BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2002-12-05 US disclosed
EP-1165633-A1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS Basell Technology Company B.V. (NL) 2002-01-02 EP disclosed
WO-2001057099-A1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS BASELL TECHNOLOGY COMPANY B.V. (NL) 2001-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020183575-A1 Components and catalysts for the polymerization of olefins SCO2, ECI1, MT-CO2 CYP4F2 138/4885CYP4A11 514/4885MAPT 2834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.